$18,252.02 consulting Payment -- Takeda Pharmaceuticals to Dr. Nicole Lopez

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Takeda Pharmaceuticals made a $18.3K consulting payment to Nicole Lopez, a Oncology specialist in Jacksonville, FL. The payment was associated with Trulicity. The payment of $18,252.02 to Dr. Nicole Lopez for consulting services related to Trulicity is a significant amount. The payment was made by Takeda Pharmaceuticals, a major pharmaceutical company. The consulting fee was paid on August 7, 2024, indicating a recent engagement.

Patient Guidance: What This Payment Means for You

If you are a patient, discuss any medications prescribed with your doctor to understand their purpose and any potential financial relationships they may have with pharmaceutical companies. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For an Oncology specialist, a consulting fee of $18,252.02 from a pharmaceutical company for services related to a diabetes medication like Trulicity is unusual and warrants further investigation into the nature of the consulting.

Regulatory Context: Sunshine Act Requirements

Physicians must disclose all payments received from pharmaceutical companies to ensure transparency and avoid potential conflicts of interest, as mandated by the Sunshine Act.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• consulting-fees
• oncology
• takeda-pharmaceuticals
• trulicity
• physician-payments

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $18.3K payment for?

This was a consulting payment of $18.3K from Takeda Pharmaceuticals to Nicole Lopez, categorized as "Consulting Fee". It was associated with Trulicity. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Nicole Lopez accept pharmaceutical money?

Yes, Nicole Lopez received this $18.3K payment from Takeda Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Nicole Lopez's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $18.3K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Oncology?

To compare this payment against Oncology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Oncology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Nicole Lopez's relationship with Takeda Pharmaceuticals?

The payment amount is substantial for a single consulting engagement. This $18.3K consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Oncology?

The payment type is 'Consulting Fee', suggesting a specific service provided.

What should patients do after learning about this payment?

If you are a patient, discuss any medications prescribed with your doctor to understand their purpose and any potential financial relationships they may have with pharmaceutical companies.

What else should I know about this consulting payment?

The drug mentioned, Trulicity, is a widely used medication for type 2 diabetes, which may or may not be directly related to Oncology practice.

Related Reports

• View Dr. Nicole Lopez's full payment report
• Takeda Pharmaceuticals full spending report
• Browse all Oncology payments
• Browse all payments in Florida
• Search for other payments